Oxford-Based Precision Health Firm Appoints New CEO
1 report, 1 independent
Updated Oct 6
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Perspectum, a precision health company based in Oxford, England, announced the appointment of Warren Cresswell as Chief Executive Officer. Cresswell brings over 25 years of experience across diagnostics, pharmaceuticals, and medical devices, including building infrastructure for FDA-cleared diagnostics in the United States.
From prnewswire.com
Why it matters
Perspectum delivers non-invasive solutions aimed at improving patient outcomes in liver and cardiometabolic disease. The CEO's background in scaling organizations and managing FDA-cleared diagnostics could support the company's expansion and advancement of its innovative technologies.
From prnewswire.com
Who's involved
Keep exploring
The entities involved
Related events
- Allarity Therapeutics has established a facility in Horsholm, Northern Europe, and the FDA requires CLIA certification for biomarker testing.
- FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- The FDA requested additional clinical data from Unicycive Therapeutics.